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The cardiology community has bypassed functional ischemic heart
disease (IHD) over the past decades, being fascinated by all exciting in-
terventional developments to manage obstructive coronary artery
disease (CAD). Vasospastic angina, an important and frequently occur-
ring functional manifestation of IHD, has been the playing ﬁeld for
passionated ‘lone wolfs’ in cardiology and for dedicated, mostly Asian or
Japanese, research groups. Meanwhile coronary interventions have only
solved part of the mechanisms of IHD and patients with recurrent, often
unpredictable and variable symptoms of angina pectoriswithout obstruc-
tive CAD are still insufﬁciently recognized and treated. The diagnosis and
treatment of vasospastic angina and other types of functional coronary
disease is an ongoing frustration for both patients and their doctors.
In the current issue of the International Journal of Cardiology a Kore-
an expert group of cardiologists in vasospastic angina report gender dif-
ferences on its prognosis in 986 patients over a follow-up period of
more than 11 years [1]. Clinical characteristics were importantly differ-
ent among the 15% includedwomen compared to themajority ofmales.
Women were younger, had less obstructive CAD and needed a higher
ergonovine dosage during provocative testing compared to men.
Smoking was almost 8 times more prevalent in men, in whom hs-CRP
levels were prognostic for adverse outcomes but not in women. Al-
though the authors are to be praised for their large sample size and
follow-up duration of patients with vasospastic angina, women repre-
sented only a minority and female-speciﬁc risk factors/variables were
importantly lacking. Between the lines some interesting observations
are noted in the Korean study: symptoms in women occurred more
often at night with predominant spontaneous and inducible spasm in
the RCA, which is also known from routine diagnostic coronary angiog-
raphy. In men spasmwasmore often inducible in the RCX. In both gen-
ders it is striking to note that in only 1.6% of patients spontaneous
vasospastic attacks with ECG changes were present. This nurtures the
uncertainty in optimally diagnosing vasospastic angina in clinical prac-
tice and underscores that inducible angina pectoris, ECG changes and/or
spasm in the laboratory do not automatically reﬂect anginal symptoms
in daily life. The prognostic association of hs-CRP in men may be more
related to their higher rate of smoking, which enhances arterial inﬂam-
mation, rather than sex-differences in hormonal status as stated by the
authors. The majority of women in this study were postmenopausal,
when sex-differences in hormonal status are less outspoken but still
remain.
1. Role of sex steroids in modulating vasomotor response
Sex steroid hormones are increasingly acknowledged as being rele-
vant to immune response and vascular inﬂammation, having a different
impact in men and women during their lifetime [2,3]. Decreased levels
of sex-steroid hormones are associated with a higher inﬂammatory
state in both men and women. During the years of menopause transi-
tion there is a huge decline in estrogen levels, whereas the decline in
testosterone levels with ageing in men is a more gradual process [4].
In adulthood men tend to have a higher inﬂammatory predisposition
than women, but the opposite accounts for women after menopause
[2]. Lower estrogen levels after menopause are related to altered vascu-
lar function, inﬂammation and upregulation of other hormonal systems
such as the renin-angiotensin system (RAS) and the sympathetic nervous
system [5]. In addition, female sex dominates in 80% of autoimmune dis-
orders, which also enhances vascular endothelial dysfunction [2,6]. Evi-
dence is increasing that coronary microvascular disease (CMD) is one of
the keymechanisms involved in accelerated atherosclerosis in chronic in-
ﬂammatory diseases [7]. The relatively higher proinﬂammatory state in
women at middle-age results in a higher susceptibility to CMD than in
men, whereas at older age when the traditional risk factors are more
prevalent, obstructive CAD in the larger coronary arteries becomes the
most common form of IHD. In contrast, vasospastic angina in the larger
epicardial arteries occurs obviously more often in men than in women,
also in Western populations, and may be provoked by their earlier ap-
pearance of non-obstructive atherosclerosis [8].
2. Role of psychosocial factors in functional ischemic heart disease
Although the male/female comparison is a crucial way to move for-
ward in our understanding of the variousmanifestations of IHD, it is also
interesting to understand why individual men or women are more
prone to vascular dysfunction/vasospasm than others. Psychosocial,
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socio-economic and behavioral factors may be evenmore relevant than
pure biological sex-differences, which have always been themain focus
of research. In the INTERHEART study psychosocial and stress-related
factors were found to be important for IHD in both genders [9]. The
prevalence of these factors is higher in women during their lifetime
with a different impact on IHD than in men. Emotional activity has re-
cently been shown to activate arterial inﬂammation, which is impor-
tantly involved in functional IHD [10]. Chronic psychological stress
inhibits many functions of the immune system, which may enhance a
higher susceptibility to endothelial dysfunction and vasospasm. Al-
though stress-related factors were not studied by Lee et al., they may
have been relevant to the observed clinical differences in angina presen-
tation amongmen and women in their study group [1]. In clinical prac-
tice psychological and stress-related factors are more difﬁcult to
measure and quantify than the ‘hard’ ﬁgures of lifestyle and the tradi-
tional risk factors that we are used to work with. In our increasingly
urban oriented way of life, personality traits, (job) stress and anxiety
are inseparably connected to the world-wide increase in burden of
IHD. This containsmore than obstructive CAD alone and demands a dif-
ferent more patient-centered multidisciplinary approach than the sec-
ondary prevention measures nowadays indicate.
Optimal management of functional IHD, such as vasospastic angina
and CMDdemands a different andmore open orientation of the cardiol-
ogy community towards functional coronary testing, which has a low
complication rate in hands of well trained and experienced intervention
cardiologists [8].
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